Flonase Nasal Spray


Approval Status
Approved November 1997

Treatment for
allergic rhinitis

Immune System , Respiratory

Flonase nasal spray has been approved by the FDA for the treatment of seasonal and perennial allergic rhintis in children four years and older. This supplementary new dosage application represents an extension of the product to include younger children.

Flonase Nasal Spray Drug Information

The Flonase Nasal Spray drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top